Table 4:
Expected and Observed Number of Cancers and Observed to Expected Ratio for Leading Cancers with Elevated Incidenceb by Region AI/AN Females, PRCDA Counties 20122016
Observed Casesc | Expected Casesd | Excess Cancers | Observed to Expected Ratio | |
---|---|---|---|---|
Northern Plains | ||||
Liver | 64 | 18 | 46 | 3.56 |
Kidney | 143 | 66 | 77 | 2.17 |
Lung | 551 | 296 | 255 | 1.86 |
Stomach | 33 | 17 | 16 | 1.94 |
Cervical | 73 | 40 | 33 | 1.83 |
Colorectal | 299 | 177 | 122 | 1.69 |
Oropharyngeal | 58 | 40 | 18 | 1.45 |
Total Excess Cancer Cases | 567 | |||
Alaska | ||||
Stomach | 33 | 8 | 25 | 4.13 |
Colorectal | 216 | 74 | 142 | 2.92 |
Oropharyngeal | 32 | 12 | 20 | 2.67 |
Liver | 19 | 9 | 10 | 2.11 |
Kidney | 54 | 28 | 26 | 1.93 |
Cervical | 26 | 16 | 10 | 1.63 |
Lung | 164 | 105 | 59 | 1.56 |
Total Excess Cancer Cases | 292 | |||
Southern Plains | ||||
Liver | 88 | 30 | 58 | 2.93 |
Stomach | 56 | 24 | 32 | 2.33 |
Kidney | 235 | 114 | 121 | 2.06 |
Cervical | 118 | 71 | 47 | 1.66 |
Pancreas | 129 | 81 | 48 | 1.59 |
Colorectal | 452 | 286 | 166 | 1.58 |
Lung | 697 | 467 | 230 | 1.49 |
Corpus and Uterus, NOS | 261 | 190 | 71 | 1.37 |
Female Breast | 1337 | 1012 | 325 | 1.32 |
Ovary | 132 | 99 | 33 | 1.33 |
Non-Hodgkin Lymphoma | I58 | 122 | 36 | 1.30 |
Thyroid | 207 | 176 | 31 | 1.18 |
Total Excess Cancer Cases | 1198 | |||
Pacific Coast | ||||
Liver | 94 | 32 | 62 | 2.94 |
Stomach | 43 | 22 | 21 | 1.95 |
Cervical | 105 | 52 | 53 | 2.02 |
Colorectal | 317 | 235 | 82 | 1.35 |
Lung | 456 | 377 | 79 | 1.21 |
Corpus and Uterus, NOS | 253 | 222 | 31 | 1.14 |
Total Excess Cancer Cases | 328 | |||
East | ||||
Liver | 22 | 11 | 11 | 2.00 |
Stomach | 25 | 12 | 13 | 2.08 |
Total Excess Cancer Cases | 24 | |||
Southwest | ||||
Liver | 138 | 40 | 98 | 3.45 |
Stomach | 93 | 30 | 63 | 3.10 |
Kidney | 208 | 111 | 97 | 1.87 |
Corpus and Uterus, NOS | 337 | 272 | 65 | 1.24 |
Total Excess Cancer Cases | 323 |
AI/AN race is reported by NPCR and SEER registries or through linkage with the IHS patient registration database. Includes only AI/AN of non-Hispanic origin. Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute’s Surveillance, Epidemiology and End Results Program (SEER)
Leading cancers with elevated incidence selected from 15 most common cancers. See Web Table 2
Observed counts are the number of cancer cases observed in the dataset
Expected counts are calculated by applying age specific cancer incidence rates from the White population to the AI/AN population